Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Aliphatic organic acid salt of berberine type alkaloid and preparation method and usage thereof

A technology of organic acid salts and alkaloids, which is applied in the field of pharmacy, can solve problems such as drug accumulation, and achieve the effects of improved bioavailability, good therapeutic effect, and high bioavailability

Inactive Publication Date: 2008-01-30
FUDAN UNIV
View PDF0 Cites 29 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

For example, the oral dosage of berberine for antibacterial use is 0.3-0.9g / day, and the dosage range for antiarrhythmia is 1.2-3g / day. Such long-term use may excessively inhibit the intestinal flora and affect the intestinal environment; new Most of the indications are chronic diseases with long-term medication. According to the literature, the average residence time of berberine in the human body is 33 hours. Long-term large-dose administration will cause drug accumulation.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Aliphatic organic acid salt of berberine type alkaloid and preparation method and usage thereof
  • Aliphatic organic acid salt of berberine type alkaloid and preparation method and usage thereof
  • Aliphatic organic acid salt of berberine type alkaloid and preparation method and usage thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0037] Example 1 Preparation of berberine laurate

[0038] Dissolve equivalent amounts of berberine sulfate and sodium laurate in 20 times the amount of 80℃ hot water, mix, continue stirring at 80℃ for 4 hours, let cool to room temperature, add the equivalent reactant (with berberine sulfate The reaction product was extracted three times with dichloromethane in an amount of 30 times the mass based on alkali and sodium laurate. The dichloromethane layer was separated and concentrated under reduced pressure. In the concentrated solution, 10 times the amount of petroleum ether was added to the filtrate to precipitate and filter. Take the precipitate, dry, and get it.

Embodiment 2

[0039] Example 2 Preparation of santengin stearate

[0040] Dissolve equivalent amounts of yellow rattan hydrochloride and sodium stearate in 10 times the amount of 90℃ hot water, mix, continue stirring at 90℃ for 4 hours, let cool to room temperature, add 20 times the amount of the reactant n-butyl The reaction product was extracted with alcohol three times, the n-butanol layer was separated, an appropriate amount of anhydrous sodium sulfate was added, shaken and stood still, filtered, the filtrate was taken and concentrated under reduced pressure, and 20 times the amount of petroleum ether was added to the concentrate to precipitate Precipitate, filter the precipitate, dry, and get it.

Embodiment 3

[0041] Example 3 Oral relative bioavailability of palmatine stearate.

[0042] Take the yellow rattan stearate prepared in Example 2 to make a solution with PEG 400, and give it to rats at a dose of 15 mg / kg. The same dose of yellow rattan hydrochloride PEG 400 solution was used as a control for comparison. Their pharmacokinetic curve characteristics and relative bioavailability. The pharmacokinetic curve shows that it has the advantages of good absorption and high bioavailability.

[0043] The classic two-compartment model after oral administration of yellow rattan stearate, the time lag is about 0.5h, the peak blood concentration is reached at 4-6h, and the elimination half-life is about 5.11h. Compared with santengin hydrochloride, the relative bioavailability of santengin stearate is 1855%, which does have the advantages of good absorption and high bioavailability.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to preparation method and application of berberine fatty group organic acid salt, pertaining to pharmacy field. The chemical general formula of barberine type alkaline of the invention is shown as a formula (I), wherein, X represents organic acid group, and the berberine type alkaline is berberin, palmatine, jaterohitine or coptisine. The invention relates berberine alkaline fatty group organic acid, which is of good oral taking absorption, can be used for preparing medical components, greatly improves the bio-availability of the alkaline type, and play comparatively better effect to the therapies of such diseases as bacterial infection, heart rate abnormity, platelet aggregation, hyperlipidemia, diabetes, hypertension, cardiac failure, etc.

Description

Technical field [0001] The invention belongs to the field of pharmacy, and relates to aliphatic organic acid salts of berberine alkaloids, and a preparation method, medicinal composition and application thereof. Background technique [0002] Berberines (berberines) alkaloids include berberine (berberine), palmatine (palmatine), jatrorrhizine (jatrorrhizine) and coptisine (coptisine). Berberine alkaloids have long been used clinically as antibacterial drugs, mainly for the treatment of diseases such as gastroenteritis and bacillary dysentery. In recent years, the new pharmacological effects of this type of alkaloids have been gradually discovered, which has attracted the attention of researchers again. The most extensive and in-depth research is its representative alkaloid-berberine. There are many reports on the pharmacological research of berberine in domestic and foreign journals, including the lipid-lowering effect and mechanism reported by Chinese scholars in Nature Medicine....

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07D455/03A61K31/4375A61K9/00A61P31/04A61P9/06A61P9/04A61P3/06A61P3/10A61P9/12
Inventor 翁伟宇黄建明仇缀百沈腾张建芳徐惠南郭济贤
Owner FUDAN UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com